This page contains the Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee) Roster, which lists the current members and the current number of vacancies for the committee.
Similar Posts
Nubratori, Inc. Torrance, CA. 483 issued 12/11/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 12/11/2025
Short Title (70 char) Nubratori, Inc. Torrance, CA. 483 issued 12/11/2025
FEI Number 3010166491
Firm Name Nubratori, Inc.
Record Type 483
State CA
Establishment Type Outsourcing FacilityResources for Biomarker Requestors
Information and resources for requestors about FDA’s Biomarker Qualification ProgramBiosimilars Research: Awards
Biosimilars Research: AwardsPharmcore Inc. dba Hallandale Pharmacy. Fort Lauderdale, FL. 483 issued 06/13/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 06/13/2025
Short Title (70 char) Pharmcore Inc. dba Hallandale Pharmacy. Fort Lauderdale, FL. 483 issued 06/13/2025
FEI Number 3014480778
Firm Name Pharmcore Inc. dba Hallandale Pharmacy
Record Type 483
State FLW.W. Industrial Group Recalls Pear Slices in Juice Due to Elevated Levels of Lead and Cadmium
W.W. Industrial Group, Inc., NY is recalling Parashore Pear Slices in juice, 15 oz, because they have the potential to be contaminated with elevated levels of lead and cadmium.FDA accepts proposal for reasonably likely surrogate endpoint for ‘MASH’ all-cause mortality or liver-related events
FDA accepts proposal for reasonably likely surrogate endpoint for ‘MASH’ all-cause mortality or liver-related events